Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Women with Polycystic Ovary Syndrome have a higher chance of getting depressed.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Women with PCOS are much more likely to experience depression.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Post-finasteride syndrome's existence is uncertain; more research needed.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Hormone therapy for trans individuals is effective and generally safe in the short term.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.